Print tissue, scaffolds, or cellular structures—without tying up your budget. Lease the 3D bioprinter that fits your workflow.
A bioprinter uses bioinks and specialized deposition techniques to create cell-based structures and tissue models. It's widely used in regenerative medicine, pharmaceutical development, and biomaterials research. The technology supports advanced modeling, cell viability studies, and tissue engineering across preclinical R&D and translational workflows.
3D bioprinters are essential for cutting-edge tissue fabrication, drug screening, and organ-on-a-chip development. But purchasing one can demand a large capital outlay—especially for systems with multi-material capabilities, integrated imaging, or sterile enclosures.
Leasing offers a faster, more flexible path to implementation. It’s ideal for academic labs exploring bioprinting for the first time, startups developing next-gen therapeutics, or production teams expanding into personalized medicine without long procurement delays.
Leasing makes sense when:
Whether you're validating constructs or scaling up biofabrication, leasing helps you stay agile while preserving your lab's budget.
Ideal for early-stage or venture-backed teams—and a smart option for any lab looking to preserve equity while scaling.
No inventory limitations. You choose the system that fits your workflow—we handle the financing.
2–5 year terms that support your budget, equipment lifecycle, and scaling timeline.
Get approved in days—not weeks—with no collateral, IP pledges, or debt covenants required.
Equipment sourcing, vendor coordination, and lease logistics are streamlined to reduce your team’s internal workload.
Our vendor relationships help resolve issues quickly—so you stay productive and hit key milestones.
Treat lease payments as operating expenses, not debt. This simplifies accounting and preserves flexibility.
Convert owned equipment into working capital. Keep it off your balance sheet and treat payments as operating expenses.
Already have a quote or PO? Just let us know the equipment you want to lease—we’ll take it from there.
Our in-house underwriting team reviews your financials fast—no outsourcing, no red tape—so you get a decision in days, not weeks.
We handle the logistics and coordinate with the vendor so you can get to work—no upfront capital required.
Don’t let capital constraints limit your lab’s biofabrication capabilities. Our leasing program is designed to remove friction from equipment procurement so you can stay focused on producing accurate, reliable results.